Wencan Wu

Dr. Wencan Wu


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
LZLin Zhang
Lin Zhang
LLLing Li
Ling Li
XWXia Wang
Xia Wang
HLHuimin Liu
Huimin Liu
YZYibin Zhang
Yibin Zhang
WTWeihong Tan
Weihong Tan
PROteolysis TArgeting Chimeras (PROTACs) induce targeted protein degradation by hijacking the intracellular ubiquitin proteasome system, thus emerging as a new strategy for drug development. However, most PROTACs generated lack cell-type selectivity and are poorly soluble in water. To address this drawback, we developed a novel PROTAC ZL216 using aptamer AS1411 as a targeting ligand of nucleolin to conjugate with a small molecule ligand of E3 ligase VHL, which shows high aqueous solubility and serum stability. Based on the differential expression of nucleolin on the cell surface, ZL216 could bind to and internalize into breast cancer cells, but not normal breast cells. Furthermore, we revealed that ZL216 promoted the formation of a nucleolin-ZL216-VHL ternary complex in breast cancer cells and potently induced nucleolin degradation in vitro and in vivo. As a result, ZL216 inhibited the proliferation and migration of breast cancer cells. These studies demonstrate that in addition to peptides and small molecule compounds, nuclei acid aptamers can also be used to generate PROTACs, which broadens the toolbox constructing PROTACs and provides a promising strategy for development of tumor-selective PROTACs.

1 January 2009 in Ophthalmology
Verified
Journal Article
Closed access
WWWencan Wu
Wencan Wu
WYWentao Yan
Wentao Yan
JMJulia K. MacCallum
Julia K. MacCallum
YTYunhai Tu
Yunhai Tu
AJAlice C. Jiang
Alice C. Jiang
JQJia Qu
Jia Qu

10 March 2021 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
HLHuirong Li
Huirong Li
BLBo Liu
Bo Liu
LLLili Lian
Lili Lian
JZJiajia Zhou
Jiajia Zhou
SXShengJin Xiang
ShengJin Xiang
LHLing Hou
Ling Hou
Background: Oxidative stress is a common cause of neurodegeneration and plays a central role in retinal degenerative diseases. Heme oxygenase-1 (HMOX1) is a redox-regulated enzyme that is induced in neurodegenerative diseases and acts against oxidative stress but can also promote cell death, a phenomenon that is still unexplained in molecular terms. Here, we test whether HMOX1 has opposing effects during retinal degeneration and investigate the molecular mechanisms behind its pro-apoptotic role. Methods: Basal and induced levels of HMOX1 in retinas are examined during light-induced retinal degeneration in mice. Light damage-independent HMOX1 induction at two different expression levels is achieved by intraocular injection of different doses of an adeno-associated virus vector expressing HMOX1. Activation of Müller glial cells, retinal morphology and photoreceptor cell death are examined using hematoxylin-eosin staining, TUNEL assays, immunostaining and retinal function are evaluated with electroretinograms. Downstream gene expression of HMOX1 is analyzed by RNA-seq, qPCR examination and western blotting. The role of one of these genes, the pro-apoptotic DNA damage inducible transcript 3 (Ddit3), is analyzed in a line of knockout mice. Results: Light-induced retinal degeneration leads to photoreceptor degeneration and concomitant HMOX1 induction. HMOX1 expression at low levels before light exposure prevents photoreceptor degeneration but expression at high levels directly induces photoreceptor degeneration even without light stress. Photoreceptor degeneration following high level expression of HMOX1 is associated with a mislocalization of rhodopsin in photoreceptors and an increase in the expression of DDIT3. Genetic deletion of Ddit3 in knockout mice prevents photoreceptor cell degeneration normally resulting from high level HMOX1 expression. Conclusion: The results reveal that the expression levels determine whether HMOX1 is protective or deleterious in the retina. Furthermore, in contrast to the protective low dose of HMOX1, the deleterious high dose is associated with induction of DDIT3 and endoplasmic reticulum stress as manifested, for instance, in rhodopsin mislocalization. Hence, future applications of HMOX1 or its regulated targets in gene therapy approaches should carefully consider expression levels in order to avoid potentially devastating effects.

30 September 2020 in Small
Verified
Journal Article
Closed access
PDF file
LKLingdan Kong
Lingdan Kong
FYFeng Yuan
Feng Yuan
PHPingping Huang
Pingping Huang
LYLu Yan
Lu Yan
ZCZhenzhai Cai
Zhenzhai Cai
YLYong Liu
Yong Liu

1 March 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
TCTongke Chen
Tongke Chen
LZLiqian Zhao
Liqian Zhao
SCShinuo Chen
Shinuo Chen
BZBin Zheng
Bin Zheng
HCHong Chen
Hong Chen
LWLihua Wang
Lihua Wang

13 October 2023 in Journal of Controlled Release
Verified
Journal Article
Open access
SZSenmiao Zhu
Senmiao Zhu
LCLili Chen
Lili Chen
MWMin Wang
Min Wang
JZJing Zhang
Jing Zhang
GCGang Chen
Gang Chen
WWWencan Wu
Wencan Wu
Optic neuropathy is the leading cause of irreversible blindness and is characterized by progressive degeneration of retinal ganglion cells (RGCs). Several studies have demonstrated that transplantation of Schwann cells (SCs) is a promising candidate therapy for optic neuropathy and that intravitreally transplanted cells exert their effect via paracrine actions. Extracellular vesicle (EV)-based therapies are increasingly recognized as a potential strategy for cell replacement therapy. In this study, we aimed to investigate the neuroprotective and regenerative effects of SC-EVs following optic nerve injury. We found that SC-EVs were internalized by RGCs in vitro and in vivo without any transfection reagents. Intriguingly, SC-EVs significantly enhanced the survival and axonal growth of primary RGCs in a coculture system. In a rat optic nerve crush model, SC-EVs mitigated RGC degeneration, prevented RGC loss, and preserved the thickness of the ganglion cell complex, as demonstrated by the statistically significant improvement in RGC counts and thickness measurements. Mechanistically, SC-EVs activated the cAMP-response element binding protein (CREB) signaling pathway and regulated reactive gliosis in ONC rats, which is crucial for RGC protection and axonal regeneration. These findings provide novel insights into the neuroprotective and regenerative properties of SC-EVs, suggesting their potential as a cell-free therapeutic strategy and natural biomaterials for neurodegenerative diseases of the central nervous system.